# GM1 Ganglioside Effects on Parkinson's Disease

> **NCT00037830** · PHASE2 · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 94 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** GM1 ganglioside
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00037830
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2012-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00037830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00037830, "GM1 Ganglioside Effects on Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00037830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*